Abstract
Many previously widely accepted neonatal transfusion practices are changing as neonatologists become more aware of the risks to their patients of multiple blood product transfusions. Recent literature and research on neonatal transfusion practice are here reviewed, and practical guidelines and trigger thresholds for blood products commonly used in neonatal medicine are proposed.
MeSH terms
-
Albumins / administration & dosage
-
Blood Transfusion / methods*
-
Blood Transfusion / standards
-
Erythrocyte Transfusion / methods
-
Erythropoietin / administration & dosage
-
Exchange Transfusion, Whole Blood / methods
-
Granulocyte-Macrophage Colony-Stimulating Factor / administration & dosage
-
Humans
-
Immunoglobulins, Intravenous
-
Infant, Newborn
-
Infant, Newborn, Diseases / therapy*
-
Patient Selection*
-
Plasma Substitutes / therapeutic use
-
Platelet Transfusion / methods
-
Recombinant Proteins
Substances
-
Albumins
-
Immunoglobulins, Intravenous
-
Plasma Substitutes
-
Recombinant Proteins
-
Erythropoietin
-
Granulocyte-Macrophage Colony-Stimulating Factor